Antifungal susceptibility in vitro determined by the etest® for Candida obtained from the oral cavity of irradiated and elderly individuals

Brazilian Dental Journal

Volumn 26, Issue 2, 2015, Pages 99-104

  de Freitas, Edimilson Martins ^a   Monteiro, Larissa Cavalcanti ^b   da Silva Fernandes, Michelle Bonfim ^a   Martelli Junior, Hercilio ^a   Bonan, Paulo Rogerio Ferreti ^b   Nobre, Sergio Avelino Mota ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Candida; EtestR; Radiotherapy; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT;

AGED; CANDIDA; DISK DIFFUSION; DRUG EFFECTS; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOUTH; PROCEDURES; RADIATION RESPONSE;

AGED; ANTIFUNGAL AGENTS; CANDIDA; DISK DIFFUSION ANTIMICROBIAL TESTS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IN VITRO TECHNIQUES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOUTH;

EID: 84929649401     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/0103-6440201300115     Document Type: Article

References (25)

1. Costa KRC, Ferreira JC, Komesu MC, Candido RC. Candida albicans and Candida tropicalis in oral candidosis: Quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. Mycopathol 2009;167:73–79.
2. Sun J, Qi C, Lafleur MD, Qi Q. Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China. Int J Oral Sci 2009;1:156–162.
3. Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Medicine Reports 2011;3:14.
4. Suryawanshi H, Ganvir SM, Hazarey VK, Wanjare VS. Oropharyngeal candidosis relative frequency in radiotherapy patient for head and neck cancer. J Oral Maxillofac Pathol. 2012;16:31-37.
5. Blozis GG, Robinson JE. Oral tissue changes caused by radiation therapy and their management. Dent Clin North Am 1968;6:643-656.
6. Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, et al.. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:47-52.
7. Azizi A, Rezaei M. Prevalence of Candida species in the oral cavity of patients undergoing head and neck radiotherapy. J Dent Res Dent Clin Dent Prospects. 2009;3:78-81.
8. Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health 2012;12:22.
9. Sanita PV, Mima EGO, Pavarina AC, Jorge JH, Machado AL, Vergani CE. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol.2013;116:562-569.
10. Bernal S, Mazuelos EM, Garcia M, Aller AI, Martinez MA, Gutierrez MJ. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 1996;24:201-204.
11. Varguez BL, Garcia AC, Tanaka LV, Garcia SS, Cepeda LAG, Vargas LOS, et al.. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol 2007;24:148-151.
12. Kirkpatrick WR, Revankar SG, Mcatee RK, Ribot-L JL, Fothergill AW, Mccarthy DI, et al.. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998;36:3007–3012.
13. Jabra-Rizk MA, Brenner TM, Mark R, Baqui AAMA, Merz WG, Falkler WA, et al.. Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol 2001;39:2015–2016.
14. Crocco EI, Mimica LMJ, Muramatu LH, Garcia C, Souza VM, Ruiz LRB, et al.. Identification of Candida species and antifungal susceptibility in vitro: A study on 100 patients with superficial candidiasis. An Bras Dermatol 2004;79:689-697.
15. Silva MRR, Costa MR, Miranda ATB, Fernandes OFL, Costa CR, Claudete R, et al.. Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients. Rev Inst Med Trop 2002;44:121-125.
16. Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR, et al.. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007;45:698– 706.
17. Belazi M, Koussidou-Eremondi T, Andreadis D, Minis S, Arrenis G. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: Prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 2004;19:347-351.
18. National Committee for Clinical Laboratory Standards. Publication M27-A: Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved Standard. National Committee for Clinical Laboratory Standards 2002;22:1-30.
19. Carvalhinho S, Costa AM, Coelho AC, Martins E, Sampaio A. Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses. Mycopathologia 2012;174:69- 76.
20. Karbach J, Walter C, Al-Nawas B. Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation. Clin Oral Investig. 2012;16:1305-1312.
21. Wingeter MA, Guilhermetti E, Shinobu CS, Takaki I, Svidzinski TI. Microbiological identification and in vitro sensitivity of Candida isolates from the oral cavity of HIV positive individuals. Revista da Sociedade Brasileira de Medicina Tropical 2007;40:272-276.
22. Bustamante B, Martins MA, Bonfietti LX, Szeszs MW, Jacobs J, Garcia C, et al.. Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru. J Med Microbiol 2014;63:855-860.
23. Gołaś M, Netsvyetayeva I, Sikora M, Piskorska K, Sulik-Tyszka B, Swoboda-Kopeć E. Trends in antifungal susceptibility of Candida species - one year observation. Pol J Microbiol 2014;63:217-222.
24. Amran F, Aziz MN, Ibrahim HM, Atiqah NH, Parameswari S, Hafiza MR, et al.. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia. J Med Microbiol 2011;60:1312-1316.
25. Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of Candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol 2014;32:44-48.